ClinicalTrials.gg
Sign In

Vitiligo clinical trials

The registry lists 343 studies for Vitiligo across more than 10 countries. 96 are recruiting or about to start. 312 of them are mainly about Vitiligo (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Vitiligo studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
132
Status unknown
65
Recruiting
48
Not yet recruiting
43
Active, not recruiting
24
Terminated
19

Phase

Phase 2
87
Phase 3
41
Phase 4
24
Phase 1
23
Early Phase 1
8

Where

United States
80
Egypt
48
France
45
China
39
Canada
29
Spain
16

Who runs them

Cairo University (24) · Assiut University (18) · Centre Hospitalier Universitaire de Nice (17) · Sohag University (13) · Incyte Corporation (12) · Henry Ford Health System (8) · University Hospital, Bordeaux (7) · Xijing Hospital (6)

What is being tested here

Drugs under test in Vitiligo studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ruxolitinib3512
Tacrolimus2311
GR2301202
Ascorbic Acid202
Upadacitinib113
Calcipotriene103
Bimatoprost103
Baricitinib112
MH004112
Crisaborole112

Drug classes tested here JAK inhibitors 5 open · Tyrosine kinase inhibitors (TKIs) 5 open · Corticosteroids 1 open · Antimetabolites 5

Coming up

20phase 3 studies under way
44studies finish main data collection within a year7 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 48 Vitiligo studies recruiting now, 13 (27%) set no upper age limit and 29 (60%) stop at 75 or younger. 18 (38%) take children under 18. 1 (2%) are for women only and 0 (0%) for men only; 8 (17%) take healthy volunteers.

Recruiting studies that take each age, of 48
AgeWomenMen
1012 (25%)12 (25%)
1843 (90%)43 (90%)
3043 (90%)43 (90%)
4043 (90%)43 (90%)
5041 (85%)41 (85%)
6538 (79%)37 (77%)
7526 (54%)25 (52%)
8518 (38%)17 (35%)

Across all 343 studies, recruiting or not: 44% stop at 75 or younger and 30% at 65; 30% take children; <1% are for women only and 1% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vitiligo studies take

Of 44 phase 2 interventional studies under Vitiligo, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 219 mo16–26 · 44 studies——
Phase 331 mo25–44 · 18 studies——
Interventional, no phase17 mo8–32 · 67 studies—19 mo8–33 · 63 studies
Observational21 mo10–… · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered6

Show 1 more

Studies

Recruiting first, then most recently updated. Showing 50 of 343. Browse all 343 → or search them.